glp-1 in type 2 diabetes Clinical Focus on Agonists Mellitus Contemporary Updates on the Physiology

Clinical trials showed an average weight loss of 15% of body weight over 68 weeks when combined with lifestyle interventions

The study also compared GLP-1 receptor agonists with other second-line diabetes medications like empagliflozin (Jardiance), dapagliflozin (Farxiga), and sitagliptin (Januvia) to see how these medications stacked up against each other in terms of mental health effects

& Theodoly, O

Calculations were made based on the comparative cycle threshold method (2DDCt)

It helps you record doses, weight, symptoms, nutrition, reminders, photos, imports, exports and optional read-only Apple Health context